Biden administration seeks billions to stop a killer: Hepatitis C
The Biden administration is seeking billions of dollars for a new push to wipe out hepatitis C, a virus that kills thousands of people annually in the U.S. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - March 9, 2023 Category: Science Authors: Emily Alpert Reyes Source Type: news
Research Uncovers Cheaper Diagnostic Tools For Chronic Hepatitis B in Africa
This study adds guidance as to when such earlier diagnosis may be attained.
“However, research is one thing, health systems strengthening another. Studies like this one add to the impetus and arm the policymakers to make the right decisions,” he says.
But he urges communities to take charge of these findings instead of leaving action in the hands of “sometimes incapacitated policymakers’ hands.”
“The question should be, what is the community saying about findings such as these? If we wait for policymakers to decide when they are going to invest in hepatitis B interventions, we will wait for the rest of our ...
Source: IPS Inter Press Service - Health - March 2, 2023 Category: International Medicine & Public Health Authors: Charles Mpaka Tags: Africa Featured Headlines Health TerraViva United Nations IPS UN Bureau IPS UN Bureau Report Malawi Source Type: news
Hepatocellular Carcinoma and Hepatitis C Virus Treatments Hepatocellular Carcinoma and Hepatitis C Virus Treatments
This review elucidates the pathogenesis of chronic HCV-induced hepatocellular carcinoma, discussing the relationship between hepatic carcinogenesis and viral eradication by antivirals.Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 27, 2023 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news
Hepatitis C, The Disease, Epidemiology, Treatment, Eradication Part 2: Global Epidemiology
In this installment, we ’ll cover current estimates of HCV burden by geographic location, genotype, age, and gender as well as the global burden of HCV morbidity and mortality. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 23, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news
Appalachia's hepatitis C infection rates soar
An increase in the abuse of injectable drugs has caused hepatitis C infection rates to more than triple in four Appalachian states, according to the CDC. (Source: CNN.com - Health)
Source: CNN.com - Health - February 15, 2023 Category: Consumer Health News Source Type: news
Hepatitis C, The Disease, Epidemiology, Treatment, Eradication Part 1: The Disease
First in a series, here we explain what hepatitis C is and how it affects the body, as well as explore the barriers to curing hepatitis and propose new strategies to eliminate the disease. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 13, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news
Pharmacy chain fined $30K after Saskatoon pharmacist flagged overbilling of Indigenous Services Canada
The pharmacy chain SRx Pharma has been fined $30,000 for overbilling Indigenous Services Canada for drugs used to treat hepatitis C, after a Saskatoon pharmacist alerted the province's regulatory body to the practice. (Source: CBC | Health)
Source: CBC | Health - February 3, 2023 Category: Consumer Health News Tags: News/Canada/Saskatoon Source Type: news
David J. Miller and Minnesota Independent Cooperative, Inc., Convicted in Multi-Million-Dollar Prescription Drug Diversion Scheme
FDA OCI, Devid Jess Miller, Santa Ana, CA, Minnesota Independent Cooperative, MIC, unlicensed, fraudulent, distribution, Rx, prescription, drugs, racketeering, enterprise, diverted, tampered, HIV, hepatitis C, mental disorders, supply chain, Mihran Stepanyan, Artur Stepanyan, laundering, criminal, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - January 27, 2023 Category: Medical Law Authors: DOJ Source Type: news
FDA Moves to Ease Rules for Blood Donations from Gay Men
WASHINGTON — The U.S. is moving to further ease restrictions on blood donations from gay and bisexual men and other groups that typically face higher risks of HIV.
The Food and Drug Administration on Friday announced draft guidelines that would do away with the current three-month abstinence requirement for donations from men who have sex with men. Instead, all potential donors would be screened with a new questionnaire that evaluates their individual risks for HIV based on sexual behavior, recent partners, and other factors.
If finalized, many gay and bisexual men in monogamous relationships would be able to donate ...
Source: TIME: Health - January 27, 2023 Category: Consumer Health News Authors: Matthew Perrone/AP Tags: Uncategorized healthscienceclimate Public Health wire Source Type: news
Janssen Announces Unblinding of Phase 3 CARTITUDE-4 Study of CARVYKTI ® (cilta-cel) as Primary Endpoint Met in Treatment of Patients with Relapsed and Refractory Multiple Myeloma
RARITAN, New Jersey, January 27, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Phase 3 CARTITUDE-4 study evaluating CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) versus pomalidomide, bortezomib, and dexamethasone (PVd) or daratumumab, pomalidomide, and dexamethasone (DPd) for the treatment of patients with relapsed and lenalidomide-refractory multiple myeloma met its primary endpoint of significant improvement in progression-free survival (PFS) at the first pre-specified interim analysis. As a result of meeting the primary endpoint, the Independent Data Monitoring Commi...
Source: Johnson and Johnson - January 27, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Hepatitis C Virus-specific Immune Responses Following DAAs Hepatitis C Virus-specific Immune Responses Following DAAs
This study investigated whether treatment of acute HCV infection with direct-acting antivirals prevents establishment of, or reverses, T-cell exhaustion.Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - January 26, 2023 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news
Rapid tests make diagnosis of Hepatitis C more accessible and closer to the community, study finds
A new study has shown the benefit of using a quick clinic-based diagnostic test for hepatitis C virus (HCV) infection over a standard laboratory-based test. The findings from the study has led to World Health Organization (WHO) guidelines recommending the adoption of the point-of-care (POC) HCV test. (Source: University of Bristol news)
Source: University of Bristol news - January 25, 2023 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Population Health Sciences, Institutes, Institutes, Bristol Population Health Science Institute; Press Release Source Type: news
Fewer Medi-Cal patients got crucial treatment for hepatitis C amid pandemic
Hepatitis C can be cured in most cases with a few months of medication. The number of Medi-Cal patients getting the treatment dropped during the pandemic. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - January 22, 2023 Category: Science Authors: Emily Alpert Reyes Source Type: news
Falling Treatment Uptake in the Hepatitis C Care Cascade Falling Treatment Uptake in the Hepatitis C Care Cascade
What are the main factors which are hindering high-income countries from achieving the World Health Organization hepatitis C elimination targets?Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - January 12, 2023 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news
Strong Support to Provide DAA Therapy to All Patients With HCV Strong Support to Provide DAA Therapy to All Patients With HCV
Direct-acting antiviral therapy significantly improves liver outcomes, nonliver outcomes, and long-term survival for patients with chronic hepatitis C virus, regardless of disease stage.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 11, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
